EFPIA - NEWSLETTER

EFPIA Newsletter 07 December 2023

Enhancing health data and patients' care

04 December 2023 Stakeholder coalition calls for legislative refinement of the EHDS

Recommendations to facilitate the resolution of five key challenges that will define the impact of the EHDS and its...

01 December 2023 EFPIA response to EHDS to the text adopted by ENVI/LIBE committee in the European Parliament...

Sharing a range of electronic health data types for secondary purposes through the EHDS can boost research and innovation,...

Innovative industry joint statement on Climate and Health

03 December 2023 Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health

By IFPMA, ABPI, EFPIA, Farmindustria, Innovative Medicines Canada, JPMA, Leem, PhRMA, vfa

Vaccines Europe pipeline review 2023

Vaccine innovation & vaccination play a key role in public health. The newly released 2023 Pipeline Review showcases vaccine manufacturers' commitment to:

Reduce preventable health threats
Save millions of lives woldwide
Contribute to health & socio-economic resilience

IMI impact on vaccines

How do IMI projects facilitate innovations in vaccine development and improve their assessment?

Watch the webinar recording.

What we are reading

You are invited to the “Vote Cardiovascular Health 2024” exhibition 06 December 2023 (EACH)

The future for Europe and the role of medical innovation 01 December 2023 (LinkedIn)

EU Pharma Wants Regulators’ Help To Simplify Digital Endpoints Landscape 30 November 2023 (Pink Sheet)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶